Key Details
Price
$1.14Annual ROE
383.46%Beta
2.04Events Calendar
Next earnings date:
Mar 25, 2025Recent quarterly earnings:
Dec 11, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Jul 16, 2024Analyst ratings
Recent major analysts updates
Dec 16, 24 Ascendiant Capital
BuyNov 11, 24 Ascendiant Capital
BuyApr 12, 23 Maxim Group
BuyOct 1, 21 Ascendiant Capital
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Alzamend Neuro doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?
ALZN
zacks.comJanuary 23, 2025
Here is how Alzamend Neuro, Inc. (ALZN) and Beam Therapeutics Inc. (BEAM) have performed compared to their sector so far this year.
3 Biotech Stocks That Could Turn $1,000 into $10,000 by 2024
ALZN
InvestorPlaceMay 24, 2023
Developing groundbreaking drugs and devices entails high costs, uncertain regulatory approval, and lucrative revenues. Those factors and more culminate to create a sector filled with dozens of biotech stocks that have 10X potential, or better.
3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year
ALZN
InvestorPlaceMay 11, 2023
Turning $1,000 into $10,000 in a year in the stock market is undoubtedly a lofty goal. Make no bones about it, it's not particularly likely to happen.
FAQ
- What is the ticker symbol for Alzamend Neuro?
- Does Alzamend Neuro pay dividends?
- What sector is Alzamend Neuro in?
- What industry is Alzamend Neuro in?
- What country is Alzamend Neuro based in?
- When did Alzamend Neuro go public?
- Is Alzamend Neuro in the S&P 500?
- Is Alzamend Neuro in the NASDAQ 100?
- Is Alzamend Neuro in the Dow Jones?
- When was Alzamend Neuro's last earnings report?
- When does Alzamend Neuro report earnings?
- Should I buy Alzamend Neuro stock now?
What is the ticker symbol for Alzamend Neuro?
The ticker symbol for Alzamend Neuro is NASDAQ:ALZN
Does Alzamend Neuro pay dividends?
No, Alzamend Neuro does not pay dividends
What sector is Alzamend Neuro in?
Alzamend Neuro is in the Healthcare sector
What industry is Alzamend Neuro in?
Alzamend Neuro is in the Biotechnology industry
What country is Alzamend Neuro based in?
Alzamend Neuro is headquartered in United States
When did Alzamend Neuro go public?
Alzamend Neuro's initial public offering (IPO) was on June 15, 2021
Is Alzamend Neuro in the S&P 500?
No, Alzamend Neuro is not included in the S&P 500 index
Is Alzamend Neuro in the NASDAQ 100?
No, Alzamend Neuro is not included in the NASDAQ 100 index
Is Alzamend Neuro in the Dow Jones?
No, Alzamend Neuro is not included in the Dow Jones index
When was Alzamend Neuro's last earnings report?
Alzamend Neuro's most recent earnings report was on Dec 11, 2024
When does Alzamend Neuro report earnings?
The next expected earnings date for Alzamend Neuro is Mar 25, 2025
Should I buy Alzamend Neuro stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions